Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

Y. Delpech, C. Coutant, L. Hsu, E. Barranger, T. Iwamoto, C. H. Barcenas, G. N. Hortobagyi, R. Rouzier, F. J. Esteva, L. Pusztai

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas'. Together they form a unique fingerprint.

Medicine & Life Sciences